
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors Of The Following Investigations: Olo Inc. (NYSE - OLO), Theratechnologies Inc. (Nasdaq - THTX), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)
Olo Inc. (NYSE - OLO)
Under the terms of the Merger Agreement, Olo will be acquired by Thoma Bravo for $10.25 per share in cash in a deal valued at approximately $2 billion. The investigation concerns whether the Olo Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal provides fair value to the Company's shareholders.
Additional information can be found at .
Theratechnologies Inc. (Nasdaq - THTX)
Under the terms of the agreement, Theratechnologies will be acquired by CB Biotechnology, LLC. for $3.01 per share in cash plus one contingent value right (“CVR”) per share for additional aggregate cash payments of up to $1.19 per CVR. The investigation concerns whether the Theratechnologies Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company's shareholders.
Additional information can be found at .
Guaranty Bancshares, Inc. (NYSE - GNTY)
Under the terms of the agreement, Guaranty will be acquired by Glacier Bancorp, Inc. (“Glacier”) (NYSE - GBCI). Guaranty shareholders are to receive 1.0000 share of Glacier stock for each Guaranty share. Based on the closing price of $41.58 for Glacier shares on June 23, 2025, the transaction would result in aggregate consideration of $476.2 million and value of $41.58 per Guaranty share. The investigation concerns whether the Guaranty Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal provides fair value to the Company's shareholders.
Additional information can be found at .
MRC Global Inc. (NYSE - MRC)
Under the terms of the Merger Agreement, MRC will be acquired by DNOW Inc. (“DNOW”) (NYSE - DNOW). MRC shareholders will receive 0.9489 shares of DNOW common stock for each share of MRC common stock. Upon completion of the transaction, DNOW and MRC shareholders will respectively own approximately 56.5% and approximately 43.5% of the combined company on a fully diluted basis. The investigation concerns whether the MRC Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company's shareholders in the combined entity.
Additional information can be found at .
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- NEXBRIDGE And NEXPLACE Raise $8M Series A To Launch Integrated Bitcoin Capital Markets Ecosystem
- Status Unveils First Gasless L2 On Linea With 100% Community Yield Allocation Mechanism
- Numerai Announces $1M Strategic Buyback Of NMR
- Option Samurai Unveils A Custom Option Screener That Lets Traders Scan For Any Options Strategy
- No. 1 Defi Protocol On Aptos, Echo, Launches Token Generation Event
- Bitget Lists PUMPUSDT For Futures Trading And Launches Trading Bot Support
Comments
No comment